Research Article
PD-L1 Immunohistochemistry Comparability and Their Correlation with Clinical Characteristics in NSCLC
Table 2
Overall agreement between assays (>1%).
| Reference | Comparison | of comparison | TP | FN | FP | TN | Sensitivity | Specificity | Agreement | κ |
| Dako22C3 | SP142 | 115 | 29 | 38 | 5 | 43 | 43.3% | 89.6% | 62.6% | 0.251 | Dako28-8 | 107 | 47 | 12 | 7 | 41 | 79.7% | 85.4% | 82.2% | 0.645 | SP142 | Dako22C3 | 115 | 29 | 5 | 38 | 43 | 85.3% | 53.1% | 62.6% | 0.299 | Dako28-8 | 109 | 21 | 7 | 34 | 47 | 75.0% | 58.0% | 62.4% | 0.251 | Dako28-8 | Dako22C3 | 107 | 47 | 7 | 12 | 41 | 87.0% | 77.4% | 82.2% | 0.645 | SP142 | 109 | 21 | 34 | 7 | 47 | 38.2% | 87.0% | 62.4% | 0.299 |
|
|
TP: true positive; TN: true negative; FP: false positive; FN: false negative; TC: tumor cells; IC: immune cells. SP142 was scored by . Cohen’s kappa coefficient ( κ). |